Pernix Therapeutics Holdings Inc (PTX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Pernix Therapeutics Holdings Inc (PTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010946
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that provides generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR) opioid agonist that is indicated for pain severe management, and long-term opioid treatment; a non-narcotic, non-addictive, and non-scheduled prescription sleep aid to treat insomnia; an antibiotic for infections of middle ear; and indications for depressive disorder in adults. Its branded and generic pharmaceuticals products span the therapeutic areas of neurology, psychiatry, and pain management. The company serves drug wholesalers, retail drug stores, and mass merchandisers. It has subsidiaries in the US and Ireland. Pernix Therapeutics is headquartered in Morristown, New Jersey, the US.

Pernix Therapeutics Holdings Inc (PTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pernix Therapeutics Holdings Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Pernix Therapeutics Holdings Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Pernix Therapeutics Files a Shelf Prospectus to Raise up to USD150 Million in Public Offering of Securities 10
Pernix Therapeutics to Raise up to USD16 Million in Public Offering of Shares 11
Debt Offering 12
Pernix Therapeutics Raises USD130 Million in Private Placement of 4.25% Notes Due 2021 12
Acquisition 14
Pernix Therapeutics May Sell Itself 14
Pernix Therapeutics Holdings Inc – Key Competitors 15
Pernix Therapeutics Holdings Inc – Key Employees 16
Pernix Therapeutics Holdings Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 07, 2017: Pernix Therapeutics Reports Third Quarter 2017 Financial Results 18
Jul 27, 2017: Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update 21
Jul 20, 2017: Pernix Therapeutics Pre-Announces Certain Preliminary Second Quarter 2017 Financial Results 24
May 15, 2017: Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update 26
Mar 28, 2017: Pernix Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results 28
Nov 10, 2016: Pernix Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update 32
Nov 07, 2016: Pernix Therapeutics Appoints Two Board Members 36
Aug 11, 2016: Pernix Therapeutics Reports Second Quarter 2016 Financial Results and Business Update 37
May 05, 2016: Pernix Therapeutics Reports First Quarter 2016 Financial Results and Business Update 40
Mar 10, 2016: Pernix Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update 42
Corporate Communications 45
Nov 16, 2017: Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors 45
Oct 17, 2017: Pernix Therapeutics Announces Planned Departure of Chief Financial Officer 46
Nov 22, 2016: Pernix appoints new board member 47
Jul 26, 2016: Pernix Therapeutics Announces Reorganization of Senior Management Team 48
Jul 07, 2016: Pernix Therapeutics Announces Restructuring of Sales Force and Operations 49
May 11, 2016: Pernix Therapeutics Announces CEO Transition 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Pernix Therapeutics Holdings Inc, Medical Equipment, Key Facts, 2016 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pernix Therapeutics Holdings Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pernix Therapeutics Holdings Inc, Deals By Market, 2011 to YTD 2017 8
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Pernix Therapeutics Files a Shelf Prospectus to Raise up to USD150 Million in Public Offering of Securities 10
Pernix Therapeutics to Raise up to USD16 Million in Public Offering of Shares 11
Pernix Therapeutics Raises USD130 Million in Private Placement of 4.25% Notes Due 2021 12
Pernix Therapeutics May Sell Itself 14
Pernix Therapeutics Holdings Inc, Key Competitors 15
Pernix Therapeutics Holdings Inc, Key Employees 16
Pernix Therapeutics Holdings Inc, Subsidiaries 17

★海外企業調査レポート[Pernix Therapeutics Holdings Inc (PTX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VeriSign Inc (VRSN):企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • K S Oils Limited:戦略・SWOT・企業財務分析
    K S Oils Limited - Strategy, SWOT and Corporate Finance Report Summary K S Oils Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sunsweet Growers Inc.:企業の戦略・SWOT・財務情報
    Sunsweet Growers Inc. - Strategy, SWOT and Corporate Finance Report Summary Sunsweet Growers Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SmarTone Mobile Communications Ltd:企業の戦略的SWOT分析
    SmarTone Mobile Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Jindal Steel & Power Ltd:企業の戦略・SWOT・財務情報
    Jindal Steel & Power Ltd - Strategy, SWOT and Corporate Finance Report Summary Jindal Steel & Power Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hamburg Commercial Bank
    Hamburg Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary Hamburg Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Svenska Handelsbanken AB:企業の戦略・SWOT・財務分析
    Svenska Handelsbanken AB - Strategy, SWOT and Corporate Finance Report Summary Svenska Handelsbanken AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cytune Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Cytune Pharma SAS (Cytune) is a developer of immunotherapeutic agents for the treatment of cancer and infectious diseases. The company’s product portfolio includes recombinant proteins and monoclonal antibodies. Its CYP0150 is a recombinant protein, which decreases metastasis numbers, tumor …
  • Newcrest Mining Limited:戦略・SWOT・企業財務分析
    Newcrest Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Newcrest Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Westside Corporation Pty Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Westside Corporation Pty Ltd (Westside) is an oil and gas company that explores and produces coal seam gas. The company provides gas seam projects such as Paranui ATP 769P, Meridian SeamGas CSG fields, Tilbrook ATP 688P, and Mount Saint Martin ATP 688P, among others. It offers Paranui ATP 76 …
  • Tokyo Electric Power Company Holdings Incorporated (9501):企業の財務・戦略的SWOT分析
    Tokyo Electric Power Company Holdings Incorporated (9501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compan …
  • COSCO SHIPPING Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    COSCO SHIPPING Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary COSCO SHIPPING Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • John Wood Group Plc (WG.):石油・ガス:M&Aディール及び事業提携情報
    Summary John Wood Group Plc (Wood) is a provider of project, engineering and technical services. The company offers comprehensive solutions that improve the performance of customers' industrial assets across the asset life cycle. Its services span from concept to decommissioning and include asset so …
  • Innergex Renewable Energy Inc:企業の発電所・SWOT分析2018
    Innergex Renewable Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Gujarat State Petroleum Corp Ltd:企業の戦略的SWOT分析
    Gujarat State Petroleum Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Huawei Investment & Holding Co., Ltd.:企業の戦略・SWOT・財務情報
    Huawei Investment & Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Huawei Investment & Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Electric Power Development Co Ltd (9513):電力:M&Aディール及び事業提携情報
    Summary Electric Power Development Co., Ltd. (J-Power) is a wholesale electric utility that supplies hydroelectric and thermal power. It owns and operates a network of hydroelectric, thermal, wind and geothermal power plants. The group provides electricity and transmission services to major electric …
  • Empresa Nacional del Petroleo:企業の戦略的SWOT分析
    Empresa Nacional del Petroleo - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆